Saturday, December 27, 2014

Endo Pharmaceuticals' revenue rises, profit drops

Endo Pharmaceuticals, which is based in Chadds Ford, reported a 57 percent increase in revenue for the fourth quarter of 2011, but acquisition costs sliced the profit by 61 percent.

Endo Pharmaceuticals' revenue rises, profit drops

Endo Pharmaceuticals, which is based in Chadds Ford, reported a 57 percent increase in revenue for the fourth quarter of 2011, but acquisition costs sliced the profit by 61 percent.

The revenues for the quarter rose to $803 million compared to $511.2 million in the same quarter of 2010.

The net income dropped from $93 million in the fourth quarter of 2010 to $36.6 million in the same period of 2011.

In June, Endo bought American Medical Systems, which helped with fourth quarter revenue, but Endo paid about $140 million in the fourth quarter to reduce the debt owed on that purchase. For the year, Endo spent $290 million on servicing that debt.

David Sell
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Business Videos:
Also on Philly.com:
Stay Connected